2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estrogenicity?

There is increasing concern that certain chemicals in the environment can cause endocrine disruption in exposed humans and wildlife. Investigations of potential effects on endocrine function have been limited mainly to interactions with hormone receptors. A need exists for the development of alternate in vitro methods to evaluate chemicals for their potential to disturb various endocrine functions via other mechanisms. Our laboratory is using the human H295R adrenocortical carcinoma cell line to examine chemicals for their potential to interfere with the activity and/or expression of several key cytochrome P450 (CYP) enzymes involved in the biosynthesis of steroid hormones. In this report we demonstrated that the commonly used 2-chloro-s-triazine herbicides atrazine, simazine, and propazine dose-dependently (0-30 microM) induced aromatase (CYP19) activity to an apparent maximum of about 2.5-fold in H295R cells. Basal- and triazine-induced aromatase activity was completely inhibited by the irreversible aromatase inhibitor 4-hydroxyandrostenedione (100 microM). The triazines increased levels of CYP19 messenger ribonucleic acid (mRNA) between 1.5- and 2-fold. The time-response profile of the induction of aromatase activity and CYP19 mRNA by the triazines was similar to that by 8-bromo-cyclic adenosine monophosphate, a known stimulant of the protein kinase-A pathway that mediates the induction of aromatase in these cells. The observed induction of aromatase, the rate-limiting enzyme in the conversion of androgens to estrogens, may be an underlying explanation for some of the reported hormonal disrupting and tumor promoting properties of these herbicides in vivo.

[1]  J. C. Eldridge,et al.  Possible antiestrogenic properties of chloro-s-triazines in rat uterus. , 1994, Journal of toxicology and environmental health.

[2]  C. Mendelson,et al.  Tissue-specific promoters regulate aromatase cytochrome P450 expression. , 1993, The Journal of steroid biochemistry and molecular biology.

[3]  D G Hoel,et al.  Medical hypothesis: xenoestrogens as preventable causes of breast cancer. , 1993, Environmental health perspectives.

[4]  S. Safe,et al.  Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[5]  Geschickter Cf,et al.  Factors influencing the development and time of appearance of mammary cancer in the rat in response to estrogen. , 1942 .

[6]  Andrew A. Rooney,et al.  Alterations in steroidogenesis in alligators (Alligator mississippiensis) exposed naturally and experimentally to environmental contaminants. , 1997, Environmental health perspectives.

[7]  J T Stevens,et al.  Chloro-s-triazine antagonism of estrogen action: limited interaction with estrogen receptor binding. , 1994, Journal of toxicology and environmental health.

[8]  A. Purohit,et al.  Control of aromatase activity in breast cancer cells: The role of cytokines and growth factors , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  A. Brodie,et al.  The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. , 1977, Endocrinology.

[10]  A. Jost Genetic and hormonal factors in sex differentiation of the brain , 1983, Psychoneuroendocrinology.

[11]  I. Bird,et al.  The NCI-H295 cell line: a pluripotent model for human adrenocortical studies , 1994, Molecular and Cellular Endocrinology.

[12]  Rosalind,et al.  Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. , 1996, Environmental health perspectives.

[13]  N. Hanley,et al.  Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids. , 1993, The Journal of clinical endocrinology and metabolism.

[14]  S. Horstman,et al.  Triazine herbicide exposure and breast cancer incidence: an ecologic study of Kentucky counties. , 1997, Environmental health perspectives.

[15]  E. Simpson,et al.  Assay of aromatase activity. , 1991, Methods in enzymology.

[16]  C. Breckenridge,et al.  Hypothesis for mammary tumorigenesis in Sprague-Dawley rats exposed to certain triazine herbicides. , 1994, Journal of toxicology and environmental health.

[17]  Y. Ito,et al.  Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. , 1994, Endocrine reviews.

[18]  C. Sonnenschein,et al.  Cytopathological effects of estradiol on the arcuate nucleus of the female rat. A possible mechanism for pituitary tumorigenesis. , 1975, The American journal of anatomy.

[19]  D. Hum,et al.  Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal. , 1993, Molecular endocrinology.

[20]  D. Dabbs,et al.  Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. , 1996, Endocrinology.

[21]  F. Berrino,et al.  Triazine herbicides and ovarian epithelial neoplasms. , 1989, Scandinavian journal of work, environment & health.

[22]  T. Foster,et al.  Residues of atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine)and its metabolities in chicken tissues. , 1976, Journal of agricultural and food chemistry.

[23]  R. Pieters,et al.  Cytotoxicity and aromatase (CYP19) activity modulation by organochlorines in human placental JEG-3 and JAR choriocarcinoma cells. , 1999, Toxicology and applied pharmacology.

[24]  J. C. Eldridge,et al.  Factors affecting mammary tumor incidence in chlorotriazine-treated female rats: hormonal properties, dosage, and animal strain. , 1994, Environmental health perspectives.

[25]  D. Miller,et al.  CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. , 1994, The Journal of clinical endocrinology and metabolism.

[26]  A. Elbrecht,et al.  Aromatase enzyme activity and sex determination in chickens. , 1992, Science.

[27]  T. Triche,et al.  Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. , 1990, Cancer research.

[28]  N. Pommery,et al.  Phosphodiesterase 4 inhibitors as airways smooth muscle relaxant agents: synthesis and biological activities of triazine derivatives. , 1999, Bioorganic & medicinal chemistry.

[29]  B. Schimmer,et al.  Transcriptional regulation of the genes encoding the cytochrome P-450 steroid hydroxylases. , 1995, Vitamins and hormones.

[30]  J. Giesy,et al.  Ecological risk assessment of atrazine in North American surface waters. , 1996 .

[31]  W. Wouters,et al.  Aromatase in the human choriocarcinoma JEG-3: Inhibition by R 76 713 in cultured cells and in tumors grown in nude mice , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[33]  Sidney Udenfriend,et al.  Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range , 1972, Science.

[34]  J T Stevens,et al.  Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley and Fischer 344 rats. , 1994, Journal of toxicology and environmental health.

[35]  Z. Kelecsényi,et al.  Long-term carcinogenicity bioassay of the herbicide atrazine in F344 rats. , 1990, Neoplasma.